Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Jennifer Soung"'
Autor:
Jennifer Soung, Vivian Laquer, Joseph F. Merola, Angela Moore, Hany Elmaraghy, Chaoran Hu, Maria Lucia Buziqui Piruzeli, Evangeline Pierce, Esther Garcia Gil, Abel D. Jarell
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 8, Pp 2181-2193 (2024)
Abstract Introduction Lebrikizumab, a high-affinity IgG4 monoclonal antibody that selectively inhibits interleukin-13 with high binding affinity and slow dissociation rate, prevents the formation of the interleukin-4Rα/interleukin-13Rα1 heterodimer
Externí odkaz:
https://doaj.org/article/19f34decb7ff4f5fb3bab2dce88b368d
Autor:
Jennifer Soung, Sonja Ständer, Jan Gutermuth, Ignasi Pau-Charles, Zach Dawson, Fan Emily Yang, Luna Sun, Evangeline Pierce, Hany Elmaraghy, Linda Stein-Gold
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground Lebrikizumab improved itch, interference of itch on sleep, and quality of life (QoL) in patients with moderate-to-severe atopic dermatitis (AD), in two Phase 3 trials at 16 weeks compared to placebo.Objectives We assess improvement
Externí odkaz:
https://doaj.org/article/c56bdf7a7a8a4644adf346f54f2ae8d3
Autor:
Amy S. Paller, Carsten Flohr, Lawrence F. Eichenfield, Alan D. Irvine, Jamie Weisman, Jennifer Soung, Ana Pinto Correia, Chitra R. Natalie, Claudia Rodriguez Capriles, Evangeline Pierce, Sarah Reifeis, Renata Gontijo Lima, Clara Armengol Tubau, Vivian Laquer, Stephan Weidinger
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 7, Pp 1517-1534 (2023)
Abstract Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disorder with limited treatment options for adolescents with moderate-to-severe disease. Lebrikizumab, a monoclonal antibody targeting interleukin (IL)-13, demonstrated clini
Externí odkaz:
https://doaj.org/article/f1994888427840c4b87a98813eff0651
Autor:
Jennifer Soung, Jennifer C. Cather, Melinda Gooderham, Caitriona Ryan, Najwa Somani, Meghan Feely, Kyoungah See, Russel Burge, Mohamed Elrayes, Gaia Gallo, April W. Armstrong
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 2, Pp 282-292 (2023)
Abstract Background People with genital psoriasis may avoid close social interactions (hugs, handshakes, kisses, touching others, or being touched), which can have a significant impact on quality of life. Ixekizumab, an interleukin 17A antagonist, de
Externí odkaz:
https://doaj.org/article/ffcd1adcd24c46c0986747258116f460
Autor:
Gil Yosipovitch, Jennifer Soung, Jonathan Weiss, Elisa Muscianisi, Xiangyi Meng, Isabelle Gilloteau, Boni E. Elewski
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 9, Pp 820-821 (2019)
Externí odkaz:
https://doaj.org/article/ae156faa223749c39a8279d07a707dd1
Autor:
Andrew Blauvelt, David M. Pariser, Stephen Tyring, Jerry Bagel, Andrew F. Alexis, Jennifer Soung, April W. Armstrong, Elisa Muscianisi, Farid Kianifard, Jennifer Steadman, Rajendra Prasad Sarkar, Sandra Garcet, James G. Krueger
Publikováno v:
Journal of Dermatological Science. 109:12-21
Autor:
Eric L. Simpson, Luna Sun, George Han, Marta Casillas, Amy M. DeLozier, Lawrence F. Eichenfield, Peter A. Lio, Jennifer Soung, Susan Ball, Yuxin Ding
Publikováno v:
Journal of Dermatological Treatment. 33:2057-2062
Background Baricitinib previously demonstrated improvements in itch and sleep disturbance versus placebo in adults with moderate-to-severe atopic dermatitis (AD). Objectives Examine if itch and sleep improvements are associated with better quality of
Autor:
Amy S. Paller, Melinda Gooderham, Jennifer Soung, David Rubenstein, Linda Stein Gold, Anna M Tallman
Publikováno v:
Journal of the American Academy of Dermatology. 84:632-638
Background Tapinarof is a topical therapeutic aryl hydrocarbon receptor modulating agent under investigation for atopic dermatitis (AD) and psoriasis treatment. Methods A phase 2b, double-blind, vehicle-controlled study randomly assigned adolescents
Autor:
Peter Lio, Yestle Kim, Sanjeev Balu, Adriana Guana, Dawn Bates, DeMauri Mackie, Halley Costantino, Amanda Lopez, Jennifer Soung
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 7:s145
Autor:
Abby Jacobson, Jennifer Soung, George Michael Lewitt, Edward Lain, Phoebe Rich, Boni E. Elewski
Publikováno v:
Journal of Dermatological Treatment. 33:261-265
We evaluated the efficacy of brodalumab in patients with nail or scalp psoriasis in three phase 3 studies (AMAGINE-1/-2/-3).In AMAGINE-1, scalp clearance, measured by the psoriasis scalp severity index (PSSI), was reported for patients who received b